Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 8/20 | 0.76 |
| ▸ | VKORC1 | Q9BQB6 | 3/20 | 0.76 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.76 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.76 |
| ▸ | ALB | P02768 | 2/20 | 0.76 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.76 |
| ▸ | PCSK7 | Q16549 | 1/20 | 0.76 |
| ▸ | MEN1 | O00255 | 1/20 | 0.76 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.76 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.74 |
| ▸ | NQO1 | P15559 | 1/20 | 0.66 |
| ▸ | LMNA | P02545 | 1/20 | 0.64 |
| ▸ | GAA | P10253 | 1/20 | 0.64 |
| ▸ | HPGD | P15428 | 1/20 | 0.64 |
| ▸ | HTT | P42858 | 1/20 | 0.64 |
| ▸ | POLB | P06746 | 1/20 | 0.61 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.60 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.60 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.60 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1649909 | 0.89 | CYP2C9 (0.80) | CYP2C9VKORC1ALDH1A1HSD17B10ALB | |
| Warfarin SCHEMBL3689 | 0.86 | CYP2C9 (1.00) | CYP2C9VKORC1ALDH1A1HSD17B10ALB | |
| Warfarin SCHEMBL3792087 | 0.86 | CYP2C9 (1.00) | CYP2C9VKORC1ALDH1A1HSD17B10ALB | |
| Warfarin SCHEMBL29400364 | 0.86 | CYP2C9 (1.00) | CYP2C9VKORC1ALDH1A1HSD17B10ALB | |
| Warfarin SCHEMBL2139452 | 0.86 | CYP2C9 (1.00) | CYP2C9VKORC1ALDH1A1HSD17B10ALB | |
| Warfarin SCHEMBL662875 | 0.86 | CYP2C9 (1.00) | CYP2C9VKORC1ALDH1A1HSD17B10ALB | |
| Warfarin SCHEMBL4439794 | 0.86 | CYP2C9 (1.00) | CYP2C9VKORC1ALDH1A1HSD17B10ALB | |
| Warfarin SCHEMBL4757598 | 0.85 | CYP2C9 (0.97) | CYP2C9VKORC1ALDH1A1HSD17B10ALB | |
| Warfarin SCHEMBL2597774 | 0.85 | CYP2C9 (0.97) | CYP2C9VKORC1ALDH1A1HSD17B10ALB | |
| Warfarin SCHEMBL13278154 | 0.85 | CYP2C9 (0.97) | CYP2C9VKORC1ALDH1A1HSD17B10ALB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2161261-B1 | Materials and methods for treating coagulation disorders | ARMETHEON INC (US) | 2013-08-28 | — | — | EP | disclosed |
| CN-1950353-B | Materials and methods for treating coagulation disorders | ARYX THERAPEUTICS | 2011-06-01 | — | — | CN | disclosed |
| US-7932405-B2 | Halogenated ester derivatives of coumarins for the treatment of coagulation disorders | ARYX THERAPEUTICS, INC. (US) | 2011-04-26 | — | — | US | disclosed |
| EP-2161261-A1 | Materials and methods for treating coagulation disorders | Aryx Therapeutics (US) | 2010-03-10 | — | — | EP | disclosed |
| EP-1735296-B1 | MATERIALS AND METHODS FOR TREATING COAGULATION DISORDERS | ARYX THERAPEUTICS (US) | 2009-12-09 | — | — | EP | disclosed |
| CN-1950353-A | Materials and methods for treating coagulation disorders | ARYX THERAPEUTICS (US) | 2007-04-18 | — | — | CN | disclosed |